Biocon Reports Rs 660 Crore Net Profit in Dec Quarter
Biocon posted a consolidated net profit of Rs 660 crore for the third quarter ended December 31, 2023, driven by strong sales. The company's revenue also grew significantly.
New Delhi, Feb 8 (PTI) Biotech firm Biocon on Thursday reported a consolidated net profit of Rs 660 crore for the third quarter ended December 31, 2023, on the back of robust sales.
The company had reported a net loss of Rs 42 crore in the October-December period of last fiscal.
Total revenue rose to Rs 4,519 crore in the third quarter as against Rs 3,020 crore in the year-ago period, Biocon Ltd said in a statement.
"A key milestone this quarter was the successful conclusion of the transition of the acquired business by Biocon Biologics and a pre-payment of USD 200 million towards the acquisition-related debt reduction," Biocon Executive Chairperson Kiran Mazumdar Shaw said.
Steady market shares for key biosimilars in the US and EU were complemented by the emerging markets performance which saw a number of new product launches and tender wins, she added.
The company had reported a net loss of Rs 42 crore in the October-December period of last fiscal.
Total revenue rose to Rs 4,519 crore in the third quarter as against Rs 3,020 crore in the year-ago period, Biocon Ltd said in a statement.
"A key milestone this quarter was the successful conclusion of the transition of the acquired business by Biocon Biologics and a pre-payment of USD 200 million towards the acquisition-related debt reduction," Biocon Executive Chairperson Kiran Mazumdar Shaw said.
Steady market shares for key biosimilars in the US and EU were complemented by the emerging markets performance which saw a number of new product launches and tender wins, she added.
You May Like To Read
TODAY'S MOST TRADED COMPANIES
- Company Name
- Price
- Volume
- Dharan Infra-Epc
- 0.51 ( -3.77)
- 124522529
- Vodafone Idea L
- 6.56 (+ 3.63)
- 45528922
- Sharanam Infra
- 0.43 (+ 4.88)
- 40353794
- AvanceTechnologies
- 0.75 ( 0.00)
- 37219098
- Remedium Lifecare
- 0.92 (+ 1.10)
- 30104171